New developments with bortezomib in treating multiple myeloma.
作者信息
Reddy G Kesava
出版信息
Clin Lymphoma. 2004 Mar;4(4):215-6. doi: 10.1016/s1526-9655(11)70035-5.
Abstract
摘要
相似文献
1
New developments with bortezomib in treating multiple myeloma.
Clin Lymphoma. 2004 Mar;4(4):215-6. doi: 10.1016/s1526-9655(11)70035-5.
2
[Bortezomib].
Dtsch Med Wochenschr. 2006 Feb 3;131(5):214-8. doi: 10.1055/s-2006-924951.
3
Optimizing bortezomib treatment in patients with relapsed multiple myeloma.
Clin Adv Hematol Oncol. 2006 May;4(5):4-5; discussion 8; suppl 13.
4
Targeting the proteasome with bortezomib in multiple myeloma: update on therapeutic benefit as an upfront single agent, induction regimen for stem-cell transplantation and as maintenance therapy.
Am J Ther. 2012 Mar;19(2):133-44. doi: 10.1097/MJT.0b013e3181ff7a9e.
5
Update on the proteasome inhibitor bortezomib in hematologic malignancies.
Clin Lymphoma. 2004 Mar;4(4):230-7. doi: 10.3816/clm.2004.n.003.
6
Review. Clinical pharmacokinetics of bortezomib.
In Vivo. 2007 Mar-Apr;21(2):273-8.
7
Hematologic malignancies: from clinical science to clinical practice - 2nd European Congress.
IDrugs. 2006 Apr;9(4):242-6.
8
[Clinical study of bortezomib in the treatment of multiple myeloma patients with renal failure].
Zhonghua Xue Ye Xue Za Zhi. 2013 Jan;34(1):74-5.
9
Successful bone reconstruction after bortezomib therapy in a myeloma patient.
Int J Hematol. 2011 Sep;94(3):221. doi: 10.1007/s12185-011-0913-9. Epub 2011 Aug 23.
10
Bortezomib in multiple myeloma.
N Engl J Med. 2003 Sep 25;349(13):1287-8; author reply 1287-8.
Zotero 插件